Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vaccine Tax Credit In Clinton Budget Is Based On Sales To Nonprofit Groups

Executive Summary

President Clinton's tax credit to encourage the development of vaccines for targeted diseases would be based on sales to nonprofit organizations rather than the amount spent on research and development.

You may also be interested in...



Sen. Kerry, Rep. Pelosi Carry Vaccine Initiative; Clinton Cites R&D Credits

President Clinton expressed support for R&D tax credits for new vaccines for major world diseases during a March 2 meeting at the White House with senior vaccine company executives and international vaccine organizations.

Sen. Kerry, Rep. Pelosi Carry Vaccine Initiative; Clinton Cites R&D Credits

President Clinton expressed support for R&D tax credits for new vaccines for major world diseases during a March 2 meeting at the White House with senior vaccine company executives and international vaccine organizations.

Anthrax Vaccine Trial Of 1,500 Patients Could Begin In Summer 2000

An anthrax vaccine study involving 1,500 patients could begin as early as this summer.

UsernamePublicRestriction

Register

LL035386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel